Summary
Tumor cell subpopulations were isolated from parental (drug-sensitive) L1210 tumor by lectinnylon chromatography and evaluated in active, specific immunotherapy of a thioguanine-resistant L1210 subline. Cells released by mannoside were effective in causing regression of the variant subline. This effectiveness was not altered by treatment of the subpopulation with neuraminidase. Subpopulations either not binding fucose-specific columns or released from glucose-specific columns were also effective immunogens. Studies using the syngeneic EL4 lymphoma model indicated that mannoside-released cells were effective in combination chemotherapy-immunotherapy. The results further demonstrate the feasibility of this approach to active, specific immunotherapy.
Similar content being viewed by others
References
Cantrell, J. L., Killion, G. M., Kollmorgen, G. M.: Correlations between humoral immunity and successful chemotherapa-immunotherapy. Cancer Res. 36, 3051–3057 (1976)
Fidler, I. J., Kripke, M. L.: Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893–895 (1977)
Fridberg, S.: Comparison of an immunoresistant and an immunosusceptible ascites subline from the murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics. J. Natl. Cancer Inst. 48, 1463–1476 (1972)
Gutterman, J. U.: Cancer systemic active immunotherapy today — Prospects for tomorrow. Cancer Immunol. Immunother. 2, 1–9 (1977)
Hersh, E. M., Gutterman, J. U., Mavlight, G.: Immunotherapy of cancer in Man. Springfield, Ill.: Charles C. Thomas 1973
Hosokawa, M., Irsini, F., Mihich, E.: Fast- and slow-growing tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. Cancer Res. 35, 2657–2662 (1975)
Hyman, R., Stallings, V.: Complementation patterns of Thy-1 variants and evidence that antigen loss variants pre-exist in the parental population. J. Natl. Cancer Inst. 52, 492–436 (1974)
Ishidate, M., Jr., Aoshima, M., Sakurai, Y.: Population changes of a rat leukemia by different routes of transplantation. J. Natl. Cancer Inst. 53, 773–781 (1974)
Jacobs, D. M., Kripke, M. L.: Accelerated development of transplanted mammary tumors in mice pretreated with the methanol extraction residue of BCG and prevention of acceleration by concomitant specific immunization. J. Natl. Cancer Inst. 2, 219–224 (1974)
Kessel, D., Bosmann, H. B.: On the characteristics of actinomycin D resistance in L5178Y cells. Cancer Res. 30, 2695–2699 (1970)
Killion, J. J.: The immunotherapeutic value of a L1210 tumor cell vaccine depends upon the expression of cell-surface carbohydrates. Cancer Immunol. Immunother. 3, 87–91 (1977)
Killion, J. J.: Immunotherapy with tumor cell subpopulations. I. Active, specific immunotherapy of L1210 leukemia. Cancer Immunol. Immunother. 4, 115–119 (1978)
Killion, J. J., Kollmorgen, G. M.: Isolation of immunogenic tumor cells by cell-affinity chromatography. Nature 259, 674–676 (1976)
Killion, J. J., Wallenbrock, M. A., Rogers, J. A., Kollmorgen, G. M., Sansing, W. A., Cantrell, J. L.: Tumorigenicity and the expression of cell-surface carbohydrates. Nature 261, 54–56 (1976)
Killion, J. J., Wallenbrock, M. A., Kollmorgen, G. M., Sansing, W. A.: Properties of tumor cell vaccines. Cancer Res. 18, 54a (1977)
LeFever, A. V., Killion, J. J., Kollmorgen, G. M., Cantrell, J. L.: Immunotherapeutic value of neuraminidase-treated, drug-resistant tumor cells. In Vitro 10, 388a (1974)
LeFever, A. V., Killion, J. J., Kollmorgen, G. M.: Active immunotherapy of L1210 leukemia with neuraminidase-treated, drug-resistant L1210 sublines. Cancer Immunol. Immunother. 1, 211–217 (1976)
Mihich, E., Kitano, M.: Differences in the immunogenicity of leukemia L1210 sublines in DBA/2 mice. Cancer Res. 31, 1999–2010 (1971)
Nicolin, A., Vadlamudi, S., Goldin, A.: Antigenicity of L1210 leukemic sublines induced by drugs. Cancer Res. 32, 653–660 (1972)
Sedlacek, H. H., Meesmann, H., Seiler, F. R.: Regression of spontaneous mammary tumors in dogs after injection of neuraminidase-treated tumor cells. Int. J. Cancer 15, 409–416 (1975)
Wallenbrock, M. A., Killion, J. J.: Isolation of high-rate DNA synthetic cells by con A chromatography. J. Cell. Physiol. 95, 151–158 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Killion, J.J. Immunotherapy with tumor cell subpopulations. Cancer Immunol Immunother 5, 21–26 (1978). https://doi.org/10.1007/BF00199203
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199203